AMPK as a mediator of tissue preservation: time for a shift in dogma?

Publikation: Bidrag til tidsskriftReviewForskningfagfællebedømt

  • Henning Tim Langer
  • Maria Rohm
  • Marcus Da Silva Goncalves
  • Sylow, Lykke

Ground-breaking discoveries have established 5′-AMP-activated protein kinase (AMPK) as a central sensor of metabolic stress in cells and tissues. AMPK is activated through cellular starvation, exercise and drugs by either directly or indirectly affecting the intracellular AMP (or ADP) to ATP ratio. In turn, AMPK regulates multiple processes of cell metabolism, such as the maintenance of cellular ATP levels, via the regulation of fatty acid oxidation, glucose uptake, glycolysis, autophagy, mitochondrial biogenesis and degradation, and insulin sensitivity. Moreover, AMPK inhibits anabolic processes, such as lipogenesis and protein synthesis. These findings support the notion that AMPK is a crucial regulator of cell catabolism. However, studies have revealed that AMPK’s role in cell homeostasis might not be as unidirectional as originally thought. This Review explores emerging evidence for AMPK as a promoter of cell survival and an enhancer of anabolic capacity in skeletal muscle and adipose tissue during catabolic crises. We discuss AMPK-activating interventions for tissue preservation during tissue wasting in cancer-associated cachexia and explore the clinical potential of AMPK activation in wasting conditions. Overall, we provide arguments that call for a shift in the current dogma of AMPK as a mere regulator of cell catabolism, concluding that AMPK has an unexpected role in tissue preservation.

OriginalsprogEngelsk
TidsskriftNature Reviews Endocrinology
ISSN1759-5029
DOI
StatusE-pub ahead of print - 2024

Bibliografisk note

Funding Information:
H.T.L. and M.D.G. are funded as part of the CANCAN team supported by the Cancer Grand Challenges partnership funded by Cancer Research UK (CGCATF-2021/100022) and the National Cancer Institute (1 OT2 CA278685-01). L.S. received funding from The Novo Nordisk Foundation (grants NNF16OC0023418, NNF18OC0032082, NNF20OC0063577), Independent Research Council Denmark (DFF-4004-00233, 0169-00013B, 0169-00060B), the Danish Cancer Society (R302-A17605), and the Carlsberg Foundation (#CF21-0369). M.R. is funded by the European Research Council (ERC) under the European Union\u2019s Horizon 2020 research and innovation programme (#949017), the Helmholtz Association \u2013 Initiative and Networking Fund, the European Foundation for the Study of Diabetes (EFSD)/ Novo Nordisk Foundation Future Leaders Award, and the German Center for Diabetes Research (DZD).

Publisher Copyright:
© Springer Nature Limited 2024.

ID: 396860860